By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Morphotek Inc. 

210 Welsh Pool Road

Exton  Pennsylvania  19341  U.S.A.
Phone: 610-423-6100 Fax: n/a


Company News
Morphotek Announces Publication Of Phase 3 Results From Morab-003-004 Trial In Platinum-Sensitive Ovarian Cancer Patients 4/18/2016 10:36:36 AM
As part of Eisai Company (ESALY.PK)’s Strategic Plan, Morphotek Subsidiary Cuts 27 Jobs as Part of Restructuring 3/23/2016 7:08:03 AM
Morphotek Inc. Announces Collaboration With Mayo Clinic To Apply Its Folate Receptor Alpha Diagnostic Assays In A Phase II Clinical Trial In Triple-Negative Breast Cancer 2/3/2016 7:23:49 AM
CryoPort, Inc. Is Selected By Morphotek Inc. To Manage Cold Chain Logistics 1/14/2016 10:51:11 AM
Morphotek Inc. Announces An Agreement With BioCare Medical To Develop And Commercialize A Diagnostic Kit For Detection Of Mesothelin In Malignant Tissues 12/16/2015 7:21:59 AM
Morphotek Inc. Announces Phase 1 Results From MORAb-022-001 Trial In Healthy Subjects And Patients With Mild-To-Moderate Rheumatoid Arthritis 12/7/2015 7:28:33 AM
Morphotek Inc. Announces Collaboration Agreement With University of Wisconsin-Madison To Study The Immunosuppressive Effects Of Ca125 Tumor Antigen On Immune-Based Therapies For Ovarian Cancer 12/3/2015 7:23:21 AM
Morphotek Inc. Announces Initiation Of Amatuximab Study In First-Line, Unresectable, Malignant Pleural Mesothelioma Patients 11/18/2015 7:24:27 AM
Morphotek Inc. Announces Collaboration Agreement With University of Gothenburg To Develop Farletuzumab, An Investigational Anti-Folate Receptor Alpha Monoclonal Antibody, For Alpha-Particle Radioimmunotherapy In Ovarian Cancer 11/17/2015 7:24:13 AM
Morphotek Inc. Announces A License Agreement With Blaze Bioscience Inc. For The Development Of Novel Oncology Imaging Technology 11/9/2015 7:24:06 AM